Gsa Capital Partners LLP 4 D Molecular Therapeutics, Inc. Transaction History
Gsa Capital Partners LLP
- $1.32 Billion
- Q3 2024
A detailed history of Gsa Capital Partners LLP transactions in 4 D Molecular Therapeutics, Inc. stock. As of the latest transaction made, Gsa Capital Partners LLP holds 37,662 shares of FDMT stock, worth $302,049. This represents 0.03% of its overall portfolio holdings.
Number of Shares
37,662
Previous 64,882
41.95%
Holding current value
$302,049
Previous $1.36 Million
70.12%
% of portfolio
0.03%
Previous 0.1%
Shares
3 transactions
Others Institutions Holding FDMT
# of Institutions
143Shares Held
57.6MCall Options Held
137KPut Options Held
51.8K-
Bvf Inc San Francisco, CA7.38MShares$59.2 Million2.54% of portfolio
-
Ra Capital Management, L.P. Boston, MA5.1MShares$40.9 Million0.77% of portfolio
-
Black Rock Inc. New York, NY4.9MShares$39.3 Million0.0% of portfolio
-
Vr Adviser, LLC New York, NY4.4MShares$35.3 Million4.93% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.1MShares$32.9 Million1.63% of portfolio
About 4D Molecular Therapeutics, Inc.
- Ticker FDMT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 32,382,400
- Market Cap $260M
- Description
- 4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors. It develops a portfolio of gene therapy product candidates focuses in three therapeutic areas: ophthalmology, cardiology, and pulmonology. The company has three product candidates that are in clinical tr...